GF Securities Life Science Investment Conference will feature industry, regulatory and investment experts who have up-to-the-minute information on the life science industry in China.  Confirmed speakers include:

Bob Ai, PhD, MBA - Senior Vice President, Trout Group

David Beier, JD - Partner, Bay City Capital

Zengjiang Cheng - Secretary-General, Tongxieyi

Fred Craves - Partner, Bay City Capital

Jianhua Ding - Director-General, Department of Drug and Cosmetics Registration, CFDA

Zhicheng Lin - CEO, By-Health

Jiarong Luo - Chief Analyst, GF Medicine

Rogers Luo - CEO, Gilead China

Dr. Richard M. Myers - Hudsonalpha Institute President and former Chair of Department of Genetics, Stanford University School of Medicine

Dr. Ruiqing Pei - Dean, Chinese Academy of Sciences, Guangzhou Institute of Biomedical and Health

Greg B. Scott - Founder and CEO of CinaBio Group

Yanchun, Wang - Chairman, Boji Pharmaceutical

Feng Wu - Vice President, Pfizer China

Xuesheng Xiao - GM, GF Xinde

Dr. Hao Zeng - Chairman, GF Xinde

More speakers will be added as confirmed.